MGA Releases Economic Impact Report for Multinational Pharmaceutical Company
In a newly released report, MGA highlights the broad economic impact of Otsuka in the United States.
In a newly released report, MGA highlights the broad economic impact of Otsuka in the United States.
Federal legislation to legalize, regulate, and tax cannabis could have significant impacts on the federal budget.
In a new report, MGA examines the role of rebates among a subset of prescription drugs with the biggest price hikes between 2018 and 2023.
Federal legislation to legalize, regulate, and tax cannabis could have significant impacts on the federal budget.
In a new white paper, Alex Brill details the consequences of regulatory uncertainty for businesses and provides a close look at the ongoing uncertainty facing companies owned by ESOPs.
MGA latest white paper, by CEO Alex Brill, looks at the role of pharmacy benefit managers (PBMs) in the US prescription drug market.